Personal Cfo Solutions, LLC Leap Therapeutics, Inc. Transaction History

Personal Cfo Solutions, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$0.96 - $1.91 $60,638 - $120,645	-63,165 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$1.6 - $3.35 $12,800 - $26,800	-8,000 Reduced 11.24%	63,165 $111,000
Q4 2021 Feb 11, 2022	SELL	$2.08 - $3.65 $39,520 - $69,350	-19,000 Reduced 21.07%	71,165 $231,000
Q3 2021 Nov 18, 2021	BUY	$1.35 - $4.01 $16,200 - $48,120	12,000 Added 15.35%	90,165 $362,000
Q1 2021 Apr 21, 2021	BUY	$1.82 - $3.01 $9,100 - $15,049	5,000 Added 6.83%	78,165 $149,000
Q4 2020 Feb 09, 2021	SELL	$1.49 - $2.37 $22,350 - $35,550	-15,000 Reduced 17.01%	73,165 $164,000
Q3 2020 Nov 02, 2020	BUY	$1.68 - $2.17 $21,840 - $28,210	13,000 Added 17.3%	88,165 $0
Q2 2020 Aug 03, 2020	BUY	$1.39 - $2.84 $15,289 - $31,240	11,000 Added 17.14%	75,165 $157,000
Q1 2020 Apr 30, 2020	BUY	$1.06 - $2.94 $68,014 - $188,645	64,165 New	64,165 $101,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $288M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.